Roszdravnadzor commented on the situation regarding the ban on the import of Micardis to Russia 08:50

The decision of the international company Boehringer Ingelheim to stop the import of the drug Micardis to Russia will not affect the availability of drugs containing the active ingredient telmisartan in the country. This has been reported TASS In Roszdravnadzor.

“On July 13 last year, LLC Boehringer Ingelheim officially notified Roszdravnadzor that it will stop the supply of Micardis and Micardisplus to Russia from January 2023.”

“This decision does not affect the availability of telmisartan medicines for patients,” Roszdravnadzor said.

early september reportedIt is stated that Russia more than doubled its imports of pharmaceutical products from Brazil in the seven months of 2023.

We are talking about drugs such as Fiasp, Protafan and Actrapid, which are popular and in demand drugs in the treatment of diabetes. Certain types of pharmaceuticals, oral and dental hygiene products, and essential oils were also purchased.

Formerly in the State Duma contributed Free medicine bill for Russians

Source: Gazeta


More from author

UN Security Council decides to send a security assistance mission to Haiti 23:43

UN Security Council adopts resolution establishing mission to assist security in Haiti TASS.It is noteworthy that the international mission will not be a UN...

See LIVE and LIVE ONLINE on Movistar Napoli vs. Real Madrid, of the Champions League 2023-2024: where to watch, TV, channel and streaming

The White team will be looking for the three points in the home base of the current Italian champion.The second day of the Champions...

Economist explained the main factor affecting the ruble 23:23

GV Plekhanov Konstantin Ordov, Head of the Department of Financial Markets at the Russian University of Economics (REU), said that in the near future...